Wall Street Analysts Think Contineum Therapeutics, Inc. (CTNM) Could Surge 235.81%: Read This Before Placing a Bet

Contineum Therapeutics, Inc. (CTNM) closed the last trading session at $6.73, gaining 67% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $22.6 indicates a 235.8% upside potential.The mean estimate comprises five short-term price targets with a standard deviation of $4.93. While the lowest estimate of $16.00 indicates a 137.7% increase from the current price level, the most optimis ...